Objective: Unlike for bladder cancer, the impact of regional lymph node dissection for upper tract urothelial carcinoma is unclear. We explored whether patient survival was influenced by systematic regional lymph node dissection, using resection templates according to the main tumor location, during radical nephroureterectomy for upper tract urothelial carcinoma. Methods: The systematic regional lymph node dissection group was defined as cases in which the dissection of nodes and surrounding tissues followed the established template, and the nonsystematic regional lymph node dissection group as cases undergoing limited or no lymph node dissection. We performed radical nephroureterectomy on 98 consecutive patients with various stages of upper tract urothelial carcinoma from May 1994 to September 2014 at our institution. Of these, 77 patients with cTanyN0M0 of upper tract urothelial carcinoma undergoing radical nephroureterectomy were grouped into systematic regional lymph node dissection or non-systematic regional lymph node dissection cohorts according to the extent of dissection, and their outcomes compared. Results: Forty-four patients were categorized as systematic regional lymph node dissection and 33 as non-systematic regional lymph node dissection, including 17 with more limited nodal dissection and 16 with no nodal dissection. Five-year recurrence-free survival and cancer-specific survival were significantly higher in the systematic regional lymph node dissection (93% and 94%, respectively) than in the non-systematic regional lymph node dissection group (75% and 77% recurrence-free survival and cancer-specific survival, respectively). Further, 5-year recurrence-free survival and cancer-specific survival of muscle-invasive upper tract urothelial carcinoma (pT2-4) were significantly higher in the systematic regional lymph node dissection (87% and 91%, respectively) than in the non-systematic regional lymph node dissection group (59% and 62%, respectively) (P = 0.0237 and P = 0.0224). Neither recurrence-free survival nor cancer-specific survival was significantly prolonged by systematic dissection in patients with pTis-1 histology. Conclusions: Systematic regional lymph node dissection during radical nephroureterectomy for cTanyN0M0 upper tract urothelial carcinoma patients has a significantly beneficial impact on survival compared with patients undergoing more limited dissection, especially in the cases involving muscle invasion.
Introduction
Upper tract urothelial carcinoma (UTUC) is a relatively rare malignancy that accounts for~5% of all urothelial neoplasms (1) . Although the standard treatment for nonmetastatic UTUC is radical nephroureterectomy (RNU) with bladder cuff removal (2), the incidence of regional lymph node involvement in UTUC is 30-40% at the time of surgery (3) , and nodal metastasis is a negative prognostic factor (4) . Despite this, the delineation of regional lymph nodes potentially involved in UTUC is unclear, and the prognostic impact of lymph node dissection (LND) combined with RNU is controversial (5) .
Several large retrospective cohort studies have reported that LND improves survival in locally-invasive UTUC (6, 7) . In a prospective study in 2012, Rao et al. demonstrated the feasibility and safety of modified retroperitoneal LND for UTUC. However, this trial was conducted under a single-arm design and patient survival was not fully analysed (5) . In 2010, Kondo et al. suggested that use of a surgical template for LND leads to increased cancer-specific survival (7) , but this is still seen as a trend not borne out in other randomized trials (8) . Overall, no large randomized prospective study of the benefit of LND in UTUC has yet been reported.
The significance of LND in radical cystectomy has been demonstrated, and the extent of LND is close to being established for bladder cancer (BCa) with muscle invasion (9, 10) . Primary UTUC arises from the upper urothelium, much as primary BCa does from the bladder urothelium. Although UTUC has a relatively high incidence of lymph node involvement at the time of RNU (3) and exhibits more aggressive clinical behavior than BCa (11) , the optimal extent and significance of LND during RNU for UTUC have not been fully established.
We hypothesized that RNU with systematic regional lymph node dissection (SRLND) for UTUC would confer a survival benefit, similarly to its effect in BCa. Here, to test this idea, we evaluated the impact of SRLND during RNU for cTanyN0M0 UTUC on survival in comparison to patients with limited or no LND.
Materials and methods

Patients
We performed RNU on 98 patients with various stages of UTUC from May 1994 to September 2014 at our institution. Of these, 77 consecutive patients with cTanyN0M0 were included in this analysis. We excluded patients where the largest lymph nodes were >10 mm in diameter, as well as those with Stage IV disease on preoperative staging evaluation.
Before May 2010, LND during RNU was performed at the surgeon's discretion on the basis of clinical stage and/or comorbidities. From May 2010, however, all cTanyN0M0 patients prospectively underwent SRLND during RNU using the template reported by Kondo et al. (7) . The protocol for this study was approved by the Institutional Review Board of Hamamatsu University School of Medicine (Approval no. 23-163).
Surgical procedures
Patients underwent RNU with bladder cuff excision, using an open approach in 49 patients and a laparoscopic approach in the remaining 28. Of the 49, 22 operations were performed before May 2010 (retrospective) and 27 were performed after formal introduction of the Kondo template (prospective). An open procedure was usually performed in the prospective cohort to allow easier access to the inferior vena cava and the abdominal aorta. Excision of the bladder cuff was performed via a pararectal incision in both open and laparoscopic cases. In the prospective cohort the open approach for RNU was chosen in all but three patients with lower ureteral tumors where the template does not require the removal of paracaval, retrocaval and interaortocaval (right side) or para-aortic (left side) nodes. The laparoscopic approach tended to be used in the retrospective cohort, according to the surgeon's discretion.
Defined templates for SRLND and definition of dissection level groups SRLND was performed according to the method of Kondo et al. (7, 12) . Table 1 shows the extent of LND depending on tumor location and laterality. Among the 77 cases, the SRLND group was defined as cases in which the dissection of nodes and surrounding tissues followed the established template. Of the non-SRLND group, the cases resected only a part of area in the defined template was classified as the limited LND group.
Pathological findings
Tumors were staged according to the 2002 American Joint Committee on Cancer/International Union Against Cancer (AJCC/UICC) TNM classification (13) . Tumor grade was assessed according to the 1973 World Health Organization-International Society of Urologic Pathology consensus classification (14) . All surgical specimens were processed according to standard pathological evaluation procedures. Histopathological examination was performed by our institutional pathologists.
Patient follow-up
Patients underwent a history, physical examination, urinary cytology, cystoscopic evaluation of the bladder and multiphasic multidetector-row CT scan of the body every 3 months for the first year, every 6 months from the second through fifth years, and annually thereafter. MRI was performed when clinically indicated. Common-external-internal iliac, obturator SRLND, systematic regional lymph node dissection; LND, lymph node dissection.
Disease recurrence was defined as any documented recurrence by radiographic failure in extraurothelial lesions including local and distant sites. The occurrence of urothelial carcinoma in the bladder or contralateral upper tract was not included in disease recurrence.
Statistical analysis
Differences between the SRLND and the non-SRLND groups were analysed using the χ 2 -test for categorical variables and the MannWhitney U-test between the two groups and the Kruskal-Wallis test among the three groups for continuous variables. Recurrence-free survival (RFS) and Cancer-specific survival (CSS) were calculated using the Kaplan-Meier method and the log-rank test for statistical analysis. Association between exposure variables and RFS and CSS were evaluated using univariate and multivariate Cox regression models. In all statistical tests, P values <0.05 derived from twotailed tests were considered statistically significant. All tests were performed using commercial software (MedCalc®, version 15.6.1, MedCalc Software, Mariakerke, Belgium).
Results
Patient characteristics
Baseline characteristics of the 77 patients are shown in Table 2 . A total of 44 patients who underwent SRLND were compared with patients who had undergone limited (n = 17) or no LND (n = 16). The median total number of removed LNs in the SRLND group was significantly higher than that in the limited or the no LND group (12 vs 3 vs 0, P < 0.000001). The other characteristics did not differ among the three groups. There were no cases which showed positive surgical margin.
Lymph node yield in SRLND cohort
Of 44 patients who underwent SRLND, 30 cases were prospectively performed LND based on the defined template with open procedure including three cases underwent RNU laparoscopically due to lower ureteral tumor. Of 14 patients in the retrospective cohort, eight cases underwent LND with open procedure and six cases which had left renal pelvic tumor were done laparoscopically. For the two patients who had lower ureteral tumor, RNU was performed laparoscopically while they underwent LND with open approach.
In the retrospective cohort, patients who underwent LND by open procedure yielded markedly more LNs (median of 19) than patients who underwent laparoscopically (median of 9) (P = 0.0384; Table 3 ). Notably, one patient had left renal pelvic tumor was removed 28 LNs by open LND.
RFS and CSS
In all patients, the 5-year RFS and CSS were 93% and 94% in the SRLND group and 75% and 77% in the non-SRLND group (P = 0.0054 and P = 0.0151, respectively; Fig. 1a) . The 5-year RFS and CSS of muscle-invasive UUTUC (pT2-4) were 87% and 91% in the SRLND group and 59% and 62% in the non-SRLND group (P = 0.0237 and P = 0.0224, respectively; Fig. 1b) , while neither RFS nor CSS was significantly prolonged by SRLND in pTis-1 (non-muscle invasive) disease (P = 0.2695 and P = 0.5403, respectively; Fig. 1c) .
When patients were stratified according to dissection level, the 5-year RFS and CSS of the SRLND group were significantly higher than that of limited LND group (P = 0.0090 and P = 0.0077, respectively; Fig. 2a ). The 5-year RFS of the SRLND group showed a significant prolongation (P = 0.0143; Fig. 2b ) and the 5-year CSS of the SRLND group tended to increase (P = 0.0890; Fig. 2b ) compared with those of no LND group. There were no statistical differences in the 5-year RFS and CSS between limited and without LND groups (P = 0.9529 and P = 0.4410, respectively; Fig. 2c) .
Univariate Cox regression analyses demonstrated that pathological stage and dissection level were significant factors for both RFS (P = 0.0269 and P = 0.0054) and CSS (P = 0.0341 and P = 0.0151), respectively (Table 4) . Multivariate Cox regression analyses showed that SRLND was the only independent risk factor for RFS (P = 0.0252, hazard ratio [HR] 6.0015). However, LND extent was insignificant for CSS (P = 0.0654, HR 8.3508) ( Table 5 ).
Patient prognosis after RNU
Distant recurrence appeared in 12 cases at a median of 31 months after RNU (range, . This included 83% of those with limited or no LND. Of five patients with ureteral cancer who developed recurrence, the location of primary tumors in four cases presented in lower ureter. Of four patients who developed recurrence at the lymph nodes, two cases occurred within the defined template where would have been removed if SRLND was performed. Nine patients died of cancer (Table 6 ). All pathologically positive nodes were found in the patients undergoing SRLND. One pN1 patient still survives 166 months after RNU. One pN2 patient died of disease 52 months after RNU (Table 7 ).
Discussion
We found that complete dissection of the defined nodal areas according to the main tumor site, i.e. SRLND, leads to a marked improvement in survival in patients treated with RNU for cTanyN0M0 UTUC. This impact of SRLND on survival was particularly significant in patients with pT2-4 disease. The importance of SRLND on survival was also demonstrated because both RFS and CSS of the SRLND group significantly improved in comparison with the limited LND group. Systematic LND was a significant predictor for longer RFS after RNU in multivariate analysis.
Several retrospective studies have addressed the potential clinical merit of LND for accurate staging in UTUC, but did not identify a prognostic benefit. Among findings, Komatsu et al. suggested that lymphadenectomy provided accurate staging of UTUC patients but that the therapeutic benefit was limited to selected cases (15). RFS, recurrence-free survival; CSS, cancer-specific survival; HR, hazard ratio; 95% CI, 95% confidence interval; non-SRLND, limited or no LND. Bold indicates P < 0.05. muscle-invasive UTUC (18) . Finally, Kondo et al. suggested that the extent of LND should be determined by the distribution, and not by the number, of removed lymph nodes, since SRLND according to the template described by the authors showed a greater impact on patient survival (7) . On the basis of the literature pertaining to BCa, it was previously reported that LND provided pathological staging and prognostic information but also conferred a survival benefit (19, 20) . UTUC and BCa share many characteristics regarding clinical behavior (21) . We hypothesized that SRLND during RNU for UTUC might offer similar staging and therapeutic advantages to those close to being established for BCa. To date, no prospective randomized controlled study in UTUC has been reported, except for a prospective single-armed trial (5) . The present study was conducted against this background. Our study is a combined analysis of retrospective and prospective cohorts in a single institution. Our prospective observational study is a single-armed trial and has a very small sample size. Consequently, we divided previous cTanyN0M0 cases treated with RNU into systematic, limited or no LND categories depending on the extent of dissection and added them to the prospective analysis. This methodology carries the possible risk that the clinicopathologic backgrounds of the three categories might significantly differ. However, there were only a few differences in our cohorts, mainly in the tendency to have a large number of pelvic tumor cases in the no LND group and a long postoperative observation period after RNU in the limited or no LND group (Table 2) . We therefore consider that our data are sufficiently free of confounding factors for an accurate statistical analysis.
Systematic LND led to a significant prolongation of both RFS and CSS in our cohort of eligible patients. We confirmed the therapeutic role of SRLND using defined anatomical boundaries at the time of RNU. With regard to the depth of invasion, SRLND had no significant effect on RFS or CSS in superficial UTUC cases (pTis-1). These results are closely consistent with those of previous reports (7, 22) . Although SRLND was associated with a marked prolongation of survival after RNU for invasive UTUC (pT2-4), the important issue to address in determining the true indications for SRLND is whether a precise diagnosis of invasion before RNU is possible. In general, opinions are divided on the accuracy of CT scans for the diagnosis of invasion of UTUC. Fritz et al. reported that multiphasic multidetector-row CT, with its high spatial and temporal resolution, can accurately detect TCC of the upper urinary tract, with 87.8% accuracy in predicting its stage (23) . In contrast, Gandrup et al. demonstrated that a split-bolus CTU cannot distinguish between invasive and non-invasive urothelial tumors in the upper tract (24) . Despite improvements in technology, the fact that invasion is often microscopic means that the diagnosis of invasiveness by imaging studies is still difficult. Moreover, any conclusive determination of indications for SRLND is hampered by the lack of large prospective randomized controlled trials based on imaging findings.
In multivariate analysis, SRLND was a significant prognostic factor associated with RFS but not CSS. This dissociation may be due to the fact that of the 12 patients with distant recurrence after RNU, 83% had not undergone SRLND. If these recurrences resulted from limited or no LND, we speculate that SRLND might have a significant effect on RFS. On the other hand, all pN-positive cases were included in the SRLND category, and one pN1 patient remains alive with no evidence of disease at 166 months after RNU. In the pN-positive series, particularly pN1 patients, we conjecture that SRLND improved survival by removing microscopic lymph node metastases. Clinically, node-positive cases usually have a poor prognosis. The pT2-4 SRLND subjects had a longer survival in the present analysis. Dissection extent has an impact on survival in patients who may have possibility with positive nodal status. Verifying the effect on survival using multivariate analysis will require prospective randomized trials using a larger sample size.
Our study has several limitations. First, as a single institution study, the sample size was small, hampering precise analyses of findings. In addition, patients were not randomly assigned to receive SRLND, and the entire group of patients included retrospective and prospective cohorts. Accordingly, the favorable outcome in the SRLND category might be due to a degree of patient selection bias.
Conclusions
We demonstrated that SRLND during RNU for cTanyN0M0 UTUC patients has a significant impact on survival compared with limited or no LND. Although this impact was particularly strong in patients with pathological muscle invasion, accurate preoperative diagnosis of muscle invasion is difficult. We therefore emphasize that patients treated with RNU for UTUC should undergo SRLND to improve survival outcomes whenever possible.
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